Shandong Chenghui Shuangda Pharmaceutical | CAS 112101-81-2 | Related Intermediates | Manufacturers & Suppliers

CAS 112101-81-2

Chemistry, 6 End Use API, 32 Related Intermediates

Manufacturers/Suppliers

6 Suppliers

6 Suppliers

Also known as: 112101-81-2, R-(-)-5-(2-amino-propyl)-2-methoxy-benzenesulfonamide, R-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide, (r)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide, 5-[(2r)-2-aminopropyl]-2-methoxybenzenesulfonamide, 67x36a2xme

Molecular Formula

C₁₀H₁₆N₂O₃S

Molecular Weight

244.31 g/mol

InChI Key

IORITYIZDHJCGT-SSDOTTSWSA-N

FDA UNII

67X36A2XME

1 2D Structure

CAS 112101-81-2

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

5-[(2R)-2-aminopropyl]-2-methoxybenzenesulfonamide

2.1.2 InChI

InChI=1S/C10H16N2O3S/c1-7(11)5-8-3-4-9(15-2)10(6-8)16(12,13)14/h3-4,6-7H,5,11H2,1-2H3,(H2,12,13,14)/t7-/m1/s1

2.1.3 InChI Key

IORITYIZDHJCGT-SSDOTTSWSA-N

2.1.4 Canonical SMILES

CC(CC1=CC(=C(C=C1)OC)S(=O)(=O)N)N

2.1.5 Isomeric SMILES

C[C@H](CC1=CC(=C(C=C1)OC)S(=O)(=O)N)N

2.2 Other Identifiers

2.2.1 UNII

67X36A2XME

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. 112101-81-2

2. R-(-)-5-(2-amino-propyl)-2-methoxy-benzenesulfonamide

3. R-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide

4. (r)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide

5. 5-[(2r)-2-aminopropyl]-2-methoxybenzenesulfonamide

6. 67x36a2xme

7. Benzenesulfonamide,5-[(2r)-2-aminopropyl]-2-methoxy-

8. (r)-5-(2-aminopropyl)-2-methoxy Benzene Sulfonamide

9. Benzenesulfonamide, 5-((2r)-2-aminopropyl)-2-methoxy-

10. Benzenesulfonamide, 5-(2-aminopropyl)-2-methoxy-, (r)-

11. R-(-)-5-[2(2-amino-2-methyl)ethyl]-2-methoxybenzenesulfonamide

12. Unii-67x36a2xme

13. Schembl1412238

14. Dtxsid10920664

15. Amy25472

16. Mfcd07782137

17. Zinc21989067

18. Akos015900167

19. Ds-0700

20. Aminopropyl)-2-methoxybenzene Sulfonamide

21. Tamsulosin Hydrochloride Impurity B [ep]

22. A2233

23. R-5-(2-aminopropyl)-2-methoxybenzenesulfonamide

24. 101r812

25. 5-(2-aminopropyl)-2-methoxybenzene-1-sulfonamide

26. 2-methoxy-5-[(r)-2-aminopropyl]benzenesulfonamide

27. J-524215

28. 5-[(2r)-2-aminopropyl]-2-methoxybenzene-1-sulfonamide

29. R-(-)-5-(2-amino-propyl)-2-methoxybenzenesulfonamide

30. Tamsulosin Hydrochloride Impurity B [ep Impurity]

31. (r)-(-)-5-(2-aminopropyl)-2-methoxy-benzenesulfonamide

32. R-(-)-5-[2(2-amino-2-methyl)ethyl]-2-methoxybenzene Sulfonamide

33. Ra(-)-5-[2(2-amino-2-methyl)ethyl]-2-methoxybenzenesulfonamide

2.4 Create Date

2006-10-25

3 Chemical and Physical Properties

Molecular Formula	C₁₀H₁₆N₂O₃S
Molecular Weight	244.31 g/mol
XLogP3	0.2
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	4
Exact Mass	244.08816355 g/mol
Monoisotopic Mass	244.08816355 g/mol
Topological Polar Surface Area	104 Å²
Heavy Atom Count	16
Formal Charge	0
Complexity	313
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

List of Suppliers

Full Screen View

Reset Filter

Ask Us

Shandong Chenghui Shuangda Pharmace...

Shuangda Pharmaceutical has a world-class first-class production line, having GMP, FDA and other regulatory certifications.

Contact Supplier

China

Virtual Booth

Digital Content

N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]...

PDF Supplier PDF

URL Supplier Web Content

CAS Number

1911578-98-7

End Use API

Remdesivir

About the Company

Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. is specialized in R&D and production of APIs and adva...

Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. is specialized in R&D and production of APIs and advanced intermediates. With 22 years of production experience,the company has 6 workshops and 9 production lines which has 100t/month production capacity.The company is committed to maintain the standards with continuous improvements to the current standards throughout the product lifecycle.The main products include local anesthetic drugs, antiviral drugs, cardiovascular and cerebrovascular drugs, antitumor drugs, gastrointestinal drugs, diabetic drugs, veterinary drugs, and CDMO products.